Gastroparesis Trial, Recruiting (NCT06493032)

Gastroparesis Trial, Recruiting NCT06493032 Sponsor: Indiana University Condition: Gastroparesis

Printed from Voxsanity (voxsanity.com.au) — NCT06493032 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gastroparesis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been assessed by doctors at the trial centre as suitable for a procedure called G-POEM (a minimally invasive treatment for a stomach condition called gastroparesis)

Who may not be able to join:

You are pregnant or currently breastfeeding
Your gastroparesis (delayed stomach emptying) was caused by a spinal cord injury, as this makes a required test difficult to carry out
You are unable to have a specific stomach monitoring test done — this could apply if you have a history of severe skin allergies or sensitivity to creams or lotions, if the skin on your upper abdomen is damaged, has wounds, or is inflamed, or if you are unable to lie still in a relaxed, reclined position for the length of the test
You currently have any drains or tubes in your abdomen

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mohammad Al-Haddad, MD, Indiana Unversity/Indiana University Health

Phone: 317-278-9242

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06493032

Sponsor: Indiana University

Phase: Not Applicable

Status: Recruiting

Condition: Gastroparesis

Trial contact: 317-278-9242

More information: https://clinicaltrials.gov/study/NCT06493032

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been assessed by doctors at the trial centre as suitable for a procedure called G-POEM (a minimally invasive treatment for a stomach condition called gastroparesis)

Who may not be able to join:

You are pregnant or currently breastfeeding
Your gastroparesis (delayed stomach emptying) was caused by a spinal cord injury, as this makes a required test difficult to carry out
You are unable to have a specific stomach monitoring test done — this could apply if you have a history of severe skin allergies or sensitivity to creams or lotions, if the skin on your upper abdomen is damaged, has wounds, or is inflamed, or if you are unable to lie still in a relaxed, reclined position for the length of the test
You currently have any drains or tubes in your abdomen

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Indiana University

Registry

ClinicalTrials.gov

Start date

7 November 2024

Est. completion

1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Body Surface Gastric Mapping Rhythm IndexTM (GA-RI); Principal Gastric Frequency; BMI-Adjusted Amplitude (μV); Fed: Fasted Amplitude Ratio (ff-AR); SF-36

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov